surmount-1 trial tirzepatide non-diabetic obesity weight loss 🔴Tirzepatide for and diabetes prevention ⤵️ progression to T2D in prediabetes❗️#SURMOUNT1 trial‼️ 🔹 Up to 20% over 3 years with tirzepatide, reducing T2D onset by 93% vs. placebo. 🔹After Tirzepatide cuts diabetes risk by
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22





:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)



















